Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed more than $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2015 | 2014 |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2008 Research Grants

Brad Nelson, Ph.D.
The Pancreatic Cancer Biomarker Initiative
BC Cancer Agency's Trev & Joyce Deeley Research Centre in Victoria, BC

James DeCaprio, M.D.
The Pancreatic Cancer Biomarker Initiative
Dana-Farber Cancer Institute

Nita Ahuja, M.D.
Aberrant Hypermethylation of CpG Island Promoters in Pancreatic Cancer: Constructing a Hypermethylome
Johns Hopkins University

Allan Balmain, Ph.D.
Therapeutic Approaches to Pancreatic Cancer Based on K-Ras Isoform 4A Expression in Stem Cells
University of California, San Francisco

James Marks, Ph.D.
The Pancreatic Cancer Biomarker Initiative
University of California, San Francisco

Sunil R. Hingorani, M.D., Ph.D.
Oncogenic K-Ras as a Therapeutic Target for Pancreas Cancer
Fred Hutchinson Cancer Research Center

Allison Klein, Ph.D.
Identification of Pancreatic Cancer Susceptibility Genes
Johns Hopkins University

Chandan Kumar, Ph.D.
Discovery of Recurrent Gene Fusions in Pancreatic Cancer using High-Throughput Sequencing
University of Michigan

Joshua Mendell, M.D., Ph.D.
Ras-regulated microRNAs in Pancreatic Cancer
Johns Hopkins University

Jeffrey Settleman, Ph.D.
Identification and Validation of Novel Therapeutics Targets for K-Ras-mutant Pancreatic Cancer
Massachusetts General Hospital

Thomas D. Schmittgen, Ph.D.
MicroRNA Profiling in Serum of Pancreatic Adenocarcinoma Patients
Ohio State University

Brian Cao, M.D.

The Pancreatic Cancer Biomarker Initiative
Van Andel Reserach Institute

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303